The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Synergistic anti-tumor activity of the mTOR inhibitor everolimus and gemcitabine for the treatment of peripheral T cell lymphoma.
 
Ling Huang
No Relationships to Disclose
 
Fen Zhang
No Relationships to Disclose
 
Diwen Pang
No Relationships to Disclose
 
Yan Teng
No Relationships to Disclose
 
Xinmiao Jiang
No Relationships to Disclose
 
Lu Pan
No Relationships to Disclose
 
Yichen Sun
No Relationships to Disclose
 
Hanguo Guo
No Relationships to Disclose
 
Xiaojuan Wei
No Relationships to Disclose
 
Feili Chen
No Relationships to Disclose
 
Sichu Liu
No Relationships to Disclose
 
Caidi Lin
No Relationships to Disclose
 
Yali Wang
No Relationships to Disclose
 
Ning Wang
No Relationships to Disclose
 
Zhanli Liang
No Relationships to Disclose
 
Yilan Huang
No Relationships to Disclose
 
Choon Kiat Ong
Patents, Royalties, Other Intellectual Property - Publication number: WO/2019/070204. “Methods For Treating Lymphomas.” Singapore Patent Application 10201708262R. (Filing date: 6th Oct 2017). International Application No.: PCT/SG2018/050509. International Filing Date: 08.10.2018.
 
Qingling Zhang
No Relationships to Disclose
 
Jing Tan
No Relationships to Disclose
 
Wenyu Li
No Relationships to Disclose